Airway responsiveness after antigen inhalation challenge in hypersensitive pneumonia. 1985

W Hida, and Y Konishi, and R Kikuchi, and H Shibata, and T Fuyuki, and K Sekizawa, and H Sasaki, and T Takishima

We performed pulmonary function tests after antigen inhalation challenge in 6 patients with hypersensitive pneumonia. 2 patients showed a reduction in maximal expiratory flow at 25% vital capacity (V25) within the first 1-3 h (early reaction) followed by a decrease in vital capacity, forced expiratory volume at 1 s and increased respiratory resistance in the next 4-7 h (late reaction). In the other 4 patients, only V25 decreased within the first 1-3 h. Diffusion capacity did not change significantly. It is suggested that the small airway is the most sensitive site of reaction to an antigen inhalation challenge in hypersensitive pneumonia and that the obstructive change of the small airway could occur as the early reaction.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008448 Maximal Expiratory Flow Rate The airflow rate measured during the first liter expired after the first 200 ml have been exhausted during a FORCED VITAL CAPACITY determination. Common abbreviations are MEFR, FEF 200-1200, and FEF 0.2-1.2. Forced Expiratory Flow 0.2-1.2,Forced Expiratory Flow 200-1200,Flow Rate, Maximal Expiratory,MEFR,Forced Expiratory Flow 0.2 1.2,Forced Expiratory Flow 200 1200
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D012130 Respiratory Hypersensitivity A form of hypersensitivity affecting the respiratory tract. It includes ASTHMA and RHINITIS, ALLERGIC, SEASONAL. Airway Hyperresponsiveness,Hypersensitivity, Respiratory,Airway Hyper-Responsiveness,Airway Hyper Responsiveness,Airway Hyperresponsivenesses,Hyper-Responsiveness, Airway,Hyperresponsiveness, Airway,Respiratory Hypersensitivities
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W Hida, and Y Konishi, and R Kikuchi, and H Shibata, and T Fuyuki, and K Sekizawa, and H Sasaki, and T Takishima
January 1989, Japanese journal of medicine,
W Hida, and Y Konishi, and R Kikuchi, and H Shibata, and T Fuyuki, and K Sekizawa, and H Sasaki, and T Takishima
August 1998, American journal of respiratory and critical care medicine,
W Hida, and Y Konishi, and R Kikuchi, and H Shibata, and T Fuyuki, and K Sekizawa, and H Sasaki, and T Takishima
October 2007, Proceedings of the National Academy of Sciences of the United States of America,
W Hida, and Y Konishi, and R Kikuchi, and H Shibata, and T Fuyuki, and K Sekizawa, and H Sasaki, and T Takishima
October 1993, The American review of respiratory disease,
W Hida, and Y Konishi, and R Kikuchi, and H Shibata, and T Fuyuki, and K Sekizawa, and H Sasaki, and T Takishima
October 1988, Journal of applied physiology (Bethesda, Md. : 1985),
W Hida, and Y Konishi, and R Kikuchi, and H Shibata, and T Fuyuki, and K Sekizawa, and H Sasaki, and T Takishima
July 1988, Journal of applied physiology (Bethesda, Md. : 1985),
W Hida, and Y Konishi, and R Kikuchi, and H Shibata, and T Fuyuki, and K Sekizawa, and H Sasaki, and T Takishima
January 1988, Immunopharmacology,
W Hida, and Y Konishi, and R Kikuchi, and H Shibata, and T Fuyuki, and K Sekizawa, and H Sasaki, and T Takishima
June 1989, The European respiratory journal. Supplement,
W Hida, and Y Konishi, and R Kikuchi, and H Shibata, and T Fuyuki, and K Sekizawa, and H Sasaki, and T Takishima
August 2006, American journal of respiratory cell and molecular biology,
W Hida, and Y Konishi, and R Kikuchi, and H Shibata, and T Fuyuki, and K Sekizawa, and H Sasaki, and T Takishima
January 2000, Respiratory medicine,
Copied contents to your clipboard!